Double maintains 4 strategies that include INVA - Innoviva, Inc.
Yahoo
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...
Yahoo
WALTHAM, Mass. & GENEVA, June 12, 2025--Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), in collaboration with the Global Antibiotic Research & Development Partnership (GARDP), today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for zoliflodacin, an investigational first-in-class, single dose, spiropyrimidinetrione oral antibiotic for the treatment of uncomplicated gonorrhea in adults
Yahoo
WALTHAM, Mass. & GENEVA, Switzerland, June 10, 2025--Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), in collaboration with the Global Antibiotic Research & Development Partnership (GARDP), today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for zoliflodacin, the investigational first-in-class, single dose, spiropyrimidinetrione oral antibiotic for the treatment of uncomplicated gonorrhea in adults and
Finnhub
Presenter SpeechUnknown Analyst All right. Great. We're just about at time, so let's get started. Our next presentation is with Innoviva. I'm very pleased to welcome Pavel Raifeld, CEO. And my name
SeekingAlpha
Discover how Innoviva's diversified model drives growth through GSK royalties and specialty therapeutics.
Yahoo
BURLINGAME, Calif., June 03, 2025--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today announced that management will participate in the following upcoming investor conferences in June:
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PLCE | -0.01% | $107.07M | -37.44% | 0.00% |
VSTA | -0.14% | $344.07M | +39.29% | 0.00% |
TME | 0.15% | $13.41B | +28.31% | 0.94% |
SOL | -0.21% | $96.48M | +16.05% | 0.00% |
TKC | -0.22% | $5.40B | -21.25% | 5.10% |
ANF | 0.28% | $4.28B | -50.01% | 0.00% |
CLS | 0.35% | $17.81B | +164.65% | 0.00% |
FIVE | 0.38% | $7.23B | +21.13% | 0.00% |
OXBR | 0.42% | $16.90M | +1.79% | 0.00% |
STNG | 0.43% | $2.14B | -48.70% | 3.80% |
FATBB | -0.52% | $49.01M | -5.66% | 10.18% |
ALAB | -0.72% | $14.61B | +49.26% | 0.00% |
DAO | 0.72% | $262.76M | +119.32% | 0.00% |
DV | 0.73% | $2.46B | -24.66% | 0.00% |
CYD | 0.76% | $890.68M | +164.07% | 3.83% |
NFE | 0.78% | $1.06B | -80.94% | 0.00% |
SLE | 0.79% | $4.57M | -84.82% | 0.00% |
SOHU | 1.09% | $411.60M | -3.66% | 0.00% |
CIG.C | 1.09% | $2.65B | +29.61% | 0.00% |
DLNG | -1.23% | $131.88M | -7.91% | 4.05% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
K | -11.54% | $27.76B | +41.17% | 2.85% |
EW | -7.63% | $45.18B | -15.44% | 0.00% |
PULM | -5.93% | $25.57M | +219.63% | 0.00% |
MOGO | -4.78% | $62.89M | +73.65% | 0.00% |
QXO | -4.73% | $14.47B | -66.08% | 0.00% |
DFDV | -4.61% | $300.56M | +2,130.16% | 0.00% |
CYCN | -4.48% | $10.59M | +46.35% | 0.00% |
SHLS | -4.19% | $914.45M | -9.29% | 0.00% |
VSA | -3.25% | $8.67M | -19.04% | 0.00% |
ZCMD | -2.99% | $29.55M | -8.59% | 0.00% |
CMTL | -2.77% | $76.72M | -19.20% | 0.00% |
HUSA | -2.72% | $19.66M | -19.53% | 0.00% |
MVO | -2.20% | $66.47M | -37.17% | 21.45% |
CEG | -2.13% | $96.10B | +45.97% | 0.48% |
AVNW | -2.13% | $313.42M | -12.23% | 0.00% |
ASPS | -1.96% | $108.30M | -4.13% | 0.00% |
GME | -1.81% | $10.71B | -1.72% | 0.00% |
IMDX | -1.63% | $86.94M | -0.65% | 0.00% |
FUBO | -1.58% | $1.25B | +178.63% | 0.00% |
ARRY | -1.57% | $1.06B | -31.16% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ALEX | 43.68% | $1.31B | +7.39% | 4.97% |
OGS | 42.99% | $4.33B | +13.41% | 3.66% |
ORI | 42.81% | $9.28B | +30.84% | 2.95% |
MGEE | 42.52% | $3.26B | +19.26% | 2.02% |
LXP | 42.21% | $2.48B | -10.45% | 6.36% |
CPK | 41.25% | $2.84B | +13.89% | 2.13% |
PNW | 41.15% | $10.77B | +19.40% | 3.95% |
GTY | 40.72% | $1.55B | +4.64% | 6.67% |
NMIH | 40.68% | $3.32B | +24.25% | 0.00% |
ATO | 40.67% | $24.07B | +31.56% | 2.25% |
STAG | 40.39% | $6.84B | +1.64% | 4.05% |
BBSI | 40.07% | $1.10B | +30.64% | 0.75% |
DOX | 39.51% | $10.20B | +17.41% | 2.18% |
AWR | 39.08% | $2.98B | +8.16% | 2.41% |
BFS | 38.89% | $851.42M | -4.09% | 6.70% |
NWN | 38.77% | $1.64B | +14.66% | 4.81% |
NXRT | 38.65% | $853.36M | -12.63% | 5.90% |
OGE | 38.53% | $8.90B | +24.24% | 3.80% |
ESNT | 38.41% | $6.20B | +9.28% | 1.92% |
VRE | 38.40% | $1.37B | -2.14% | 2.53% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SMMV | 47.13% | $317.06M | 0.2% |
PBE | 46.63% | $223.19M | 0.58% |
VHT | 46.62% | $15.35B | 0.09% |
IBB | 46.57% | $5.26B | 0.45% |
FHLC | 46.42% | $2.44B | 0.084% |
PINK | 46.20% | $130.57M | 0.5% |
FVD | 45.97% | $8.98B | 0.61% |
IXJ | 45.88% | $3.75B | 0.41% |
XPH | 45.87% | $147.96M | 0.35% |
XBI | 45.50% | $4.82B | 0.35% |
XMLV | 45.24% | $810.02M | 0.25% |
IHE | 45.16% | $550.45M | 0.39% |
PPH | 45.15% | $610.46M | 0.36% |
LVHD | 44.98% | $562.24M | 0.27% |
FXG | 44.97% | $294.43M | 0.63% |
XLV | 44.92% | $34.28B | 0.09% |
SPLV | 44.83% | $7.68B | 0.25% |
USMV | 44.49% | $23.82B | 0.15% |
XSLV | 44.40% | $276.65M | 0.25% |
DHS | 44.25% | $1.23B | 0.38% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -29.49% | $164.54M | 0.85% |
TAIL | -23.95% | $99.63M | 0.59% |
CLIP | -12.23% | $1.51B | 0.07% |
USDU | -7.38% | $162.43M | 0.5% |
AGZD | -6.91% | $102.70M | 0.23% |
TPMN | -6.24% | $30.70M | 0.65% |
UUP | -6.05% | $201.63M | 0.77% |
BTAL | -5.04% | $296.22M | 1.43% |
CANE | -4.25% | $10.37M | 0.29% |
TBLL | -4.23% | $2.13B | 0.08% |
SHYM | -4.04% | $357.13M | 0.35% |
XONE | -3.93% | $625.28M | 0.03% |
IVOL | -3.31% | $347.03M | 1.02% |
FTSD | -2.61% | $231.81M | 0.25% |
UNG | -2.34% | $360.54M | 1.06% |
CTA | -2.25% | $1.06B | 0.76% |
ULST | -1.61% | $654.75M | 0.2% |
DBA | -1.15% | $788.62M | 0.93% |
BSMW | -0.93% | $107.45M | 0.18% |
CARY | -0.73% | $347.36M | 0.8% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BILZ | -0.05% | $821.74M | 0.14% |
XBIL | -0.16% | $783.90M | 0.15% |
CGSM | 0.17% | $709.45M | 0.25% |
GBIL | 0.24% | $6.37B | 0.12% |
JMST | 0.32% | $4.06B | 0.18% |
DBE | 0.33% | $52.20M | 0.77% |
USL | 0.64% | $42.23M | 0.85% |
CARY | -0.73% | $347.36M | 0.8% |
OILK | 0.83% | $71.87M | 0.69% |
HYD | 0.88% | $3.32B | 0.32% |
BSMW | -0.93% | $107.45M | 0.18% |
WEAT | 1.10% | $117.15M | 0.28% |
DBA | -1.15% | $788.62M | 0.93% |
BILS | 1.59% | $3.81B | 0.1356% |
ULST | -1.61% | $654.75M | 0.2% |
KRBN | 1.67% | $160.17M | 0.85% |
USO | 1.73% | $1.13B | 0.6% |
BNO | 1.79% | $103.79M | 1% |
UGA | 2.04% | $72.33M | 0.97% |
CTA | -2.25% | $1.06B | 0.76% |
Current Value
$19.761 Year Return
Current Value
$19.761 Year Return